Shield MCD Test Gets Breakthrough Device Designation
Guardant Health’s Shield MCD test has received FDA Breakthrough Device designation for its ability to detect multiple cancer types.
Read More
Search Results for: lung cancer
NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests
NeoGenomics launched its PanTracer Family of genomic profiling tests and Paletrra, an AI-driven spatial proteomics platform.
Read More
New PCR Chip Design: High Pressure Liquid Seal Eliminates Bubbles and Prevents Water Loss
A breakthrough discovery that water vapor causes bubble formation in PDMS-based PCR chips has led to a high-pressure liquid seal technique.
Read More
Neuroblastoma Diagnostics Driven by Artificial Intelligence
A study on neuroblastoma with bone or bone marrow metastasis (NB-BBM) used deep learning to uncover biomarkers.
Read More
CAP Lab Accreditation Updates Integrate CLIA Final Rule Changes
2024 CAP Laboratory Accreditation Program checklists integrate key CLIA final rule changes, revised personnel requirements, and more.
Read More